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Transcatheter closure of secondum atrial septal defect (ASD) is an alternative option to open heart surgery with good
short and long-term outcomes. For this purpose, the Amplatzer septal occluder (ASO) device is widely used.
Arrhythmias are known complications of ASD device closure including atrial ectopy and heart block.
We report a seven-year-old female patient who developed second degree atrioventricular block (AVB) within
few hours after ASD device closure using ASO device. At the seventh post-procedure day; while under close obser-
vation; patient regained sinus rhythm which was maintained thereafter. A 3-day course of prednisolone was given.
 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
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A seven-year-old girl presented to the outpa-tient department with a history of palpita-
tions on exertion for two months. It was not
associated with syncope or dizziness. She was
not on any medication. Examination revealed a
thin, young girl weighing 13 kg (below the 5th per-
centile). Her height was 109 cm (below the 5th per-
centile). Cardiovascular examination showed a
regular pulse, fixed splitting of the second heart
sound, and an ejection systolic murmur grade 3/
6 at the upper left sternal border. Pre-intervention
12-lead electrocardiogram (ECG) showed a nor-
mal sinus rhythm at a rate of 100 per minute with
a normal PR interval. There was an incomplete
right bundle branch block with QRS duration of
90 ms (Fig. 1). The echocardiogram was diagnostic
of a 20-mm atrial septal defect (ASD) secondum1016–7315  2012 King Saud University.
Production and hosting by Elsevier B.V. All rights reserved.
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http://dx.doi.org/10.1016/j.jsha.2013.01.002type with moderate dilatation of the right atrium
and right ventricle. The ASD rims were adequate
with a 15 mm rim to the superior vena cava
(SVC), 6 mm rim to the inferior vena cava (IVC),
4 mm rim to the aorta, and 6 mm rim to the atrio-
ventrivcular (AV) valves.
In the cardiac catheterization laboratory, under
general anesthesia, transesophageal echocardiog-
raphy (TEE) confirmed the diagnosis and showed
the presence of a deficient rim to the aorta and a
small rim to the AV valves.
The patient had transcatheter ASD device closure
using a 22 mm AMPLATZER Septal Occluder
(ASO) device (AGA Medical Corporation), under
fluoroscopy and TEE guidance. The device/patient
height ratio was 0.20. The procedure was uncompli-
cated and the patient was transferred to the recov-
ery area in stable condition. Eight hours after the
procedure she had an irregular rhythm. A 12-leadProduction and hosting by Elsevier
Figure 1. ECG prior to ASD device closure. Sinus rhythm, with normal PR interval and rSR in V1 (incomplete RBBB).
Figure 2. ECG after ASD device. Second degree heart block type 1 (progressive prolongation of the PR interval).
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(Mobitz I/Wenckebach periodicity) (Fig. 2).
A transthoracic echocardiogram showed that the
ASD device was in good position with no residual
shunt and no compromisation to nearby struc-
tures (SVC, IVC, Pulmonary veins, and AV
valves). There was no pericardial effusion (see
Fig. 3).
She was kept in the hospital for close observa-
tion and a twice daily ECG. Holter telemetry
recording for 24 h confirmed the presence of sec-
ond degree heart block with 2:1 conduction as well
as Wenckebach periodicity. In the third post pro-
cedure day she was started on Prednisolone
2 mg/kg/day divided every eight hours for three
days. At the seventh post cath day, her rhythm re-turned to sinus with normal AV conduction. The
24 h telemetry recording confirmed the normal
conduction with no evidence of AV block. She
was discharged home on Aspirin 5 mg/kg/day or-
ally for six months. She was seen three weeks later
and then at three and six months post interven-
tion. ECG revealed that she is still in sinus rhythm
with normal PR interval. Echo revealed that the
device is in position, with no impingement on
nearby structures and no pericardial effusion.Discussion
ASDs are one of the most common congenital
heart diseases. It is well known that ASDs may
be associated with subclinical ECG abnormalities,
Figure 3. Follow up ECG post ASD device. Resolution of heart block, sinus rhythm, normal PR interval and signs of incomplete RBBB.
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lay, and AV block [1,2].
The ECG of patients with ASD often shows
right-axis deviation, right atrial enlargement,
incomplete right bundle-branch block (secundum
ASD), superior left-axis deviation (primum ASD),
or an abnormal P-wave axis (superiorly located si-
nus venosus ASD). Complete heart block may be
present in association with familial ASD [3].
Familial ASD with AV conduction defect is an
autosomal dominant trait, with mutations in the
cardiac homeobox transcription factor gene
NKX2–5 [4,5].
Closure of an ASD either percutaneously or sur-
gically is indicated for right atrial and RV enlarge-
ment with or without symptoms. (Level of
Evidence: B)
Surgical closure has been the ‘‘gold standard’’
form of treatment, with excellent late outcome.
The development of percutaneous transcatheter
closure techniques has provided an alternative
method of closur for uncomplicated secundum
ASDs with appropriate morphology [6,7].
ASO can be used for ASD closure in infants and
young children provided the diameter of the disk
is smaller than the diameter of the atrial septum
[8,9].
Follow-up for patients after device closure re-
quires clinical assessment of symptoms of
arrhythmia, chest pain, or embolic events and
echocardiographic surveillance for device posi-
tion, residual shunting, and complications such
as thrombus formation or pericardial effusion.Reported complications after ASD catheter
intervention include residual shunt, device mis-
alignment, embolization, erosion of atrial wall or
aorta, impingement on adjacent structures (AV
valves, Coronary sinus, SVC, pulmonary veins,
Aorta) and device thrombosis. Endocarditis for
the first six months is also a possible complication
[10].
Heart block can occur during or after ASD clo-
sure using the ASO device with a frequency of
6.1% [11,12].
Johnson et al. reported a low risk of clinically
significant post-procedure arrhythmias after de-
vice placement with an incidence of 5.2% of
arrhythmias in the four months following device
placement, including atrial tachyarrhythmias,
junctional tachycardia, and heart block. Clinically
significant heart block occurred in only two of
their patients (0.3%) [13].
Cardiac arrhythmias and heart block were not of
the causes for cardiac surgery after ASD device
closure in some reported complications [14,15].
The size of the device can be a predisposing
factor for AVB after ASD closure. Device size
equal to or more than 18 mm, and a device/
height ratio equal to or more than 0.18 was re-
ported as a predisposing factor for AVB after
ASD closure [11,12].
Patients who receive 18 mm or larger device,
or a device/height ratio >0.18 need closer hemo-
dynamic and ECG monitoring during and after
the procedure. Twelve-lead ECG and 24-h Hol-
ter recordings are necessary later on, whereas
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AVB during ASO device closure may necessitate
the immediate removal of the device during the
procedure if the AVB did not improve within
30 min.
Patients with AVB that appears after the ASD
device closure need to be observed in the hospital
until hemodynamically stable and regression of
AVB is observed. Subsequent ambulatory follow-
up with Holter monitoring is required.
The mechanism of AVB secondary to ASO de-
vice could be due to continuous pressure or fric-
tion of atrial discs on the AV node, leading to
edema and AVB. This could be due to a deficient
rim to the atrioventricular valves and a small dis-
tance between the right atrial disc and the tricus-
pid valve [10].
AVB after ASD device may resolve within two
weeks after the procedure, which may or may
not be related to steroid administration [11,12].
In some series, AVB after ASO device closure of
ASDs resolves or improves spontaneously, with
no recurrence at mid-term follow-up [16].
Once it is decided to remove the device in pa-
tients with AVB after ASD device closure it is
important not to delay this to avoid ischemia
and fibrosis resulting in permanent injury of the
AV node. Leaving the device in place and insert-
ing a permanent pacemaker is also an option but
this carry the morbidity associated with pace-
maker placement, such as equipment malfunc-
tion, certain sports restrictions, infection, and the
requirement of life-long battery changes. There-
fore prompt surgical removal of the device and
ASD surgical closure could be the best option in
such situation.Conclusion
AVB is one of the important complications after
ASD device closure especially when using large
devices (18 mm or more or the device/height ratio
is more than 0.18). Close observation of the ECG
during and after the procedure is very important.
AVB after ASD device may resolve spontaneously
with or without steroids administration or may re-
quire removal of the device.
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